Two Sigma Securities’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-209
Closed -$12.5K 3774
2023
Q4
$12.5K Buy
+209
New +$14.7K ﹤0.01% 2793
2023
Q3
Sell
-156
Closed -$11.7K 3579
2023
Q2
$11.7K Sell
156
-187
-55% -$16K ﹤0.01% 2575
2023
Q1
$34.5K Buy
+343
New +$29.4K ﹤0.01% 2306
2022
Q2
Sell
-253
Closed -$14K 2934
2022
Q1
$14K Hold
253
﹤0.01% 2023
2021
Q4
$17K Buy
+253
New +$22K ﹤0.01% 1434

Other funds holding QNTM

Two Sigma Securities's QNTM Position: Q1 2024 in Review

Two Sigma Securities sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2024, closing a stake of 209 shares — an estimated $12.5K sold.

Two Sigma Securities first reported a position in QNTM in Q4 2021 and held it in 5 quarters. The position peaked at $34.5K in Q1 2023. 11 funds tracked by Wall St. Rank hold QNTM as of Q1 2024.

  • Two Sigma Securities reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 209 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2024, an estimated $12.5K.
  • Two Sigma Securities first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2021 and held it in 5 quarters.
  • Two Sigma Securities's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $34.5K in Q1 2023.
  • 11 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.